BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥1,151,149 | -¥1,168,082 | -¥1,483,733 | -¥1,481,772 |
| Dep. & Amort. | ¥0 | ¥395 | ¥16,719 | ¥35,123 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥115,679 | ¥2,814 | ¥16,878 | -¥15,265 |
| Other Non-Cash | ¥16,469 | ¥7,953 | ¥245,735 | -¥50,108 |
| Operating Cash Flow | -¥1,250,359 | -¥1,156,920 | -¥1,204,401 | -¥1,512,022 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1,370 | -¥6,194 | -¥1,760 | -¥17,646 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥80 |
| Inv. Purchases | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | ¥0 | -¥1,454 | ¥0 | ¥0 |
| Investing Cash Flow | -¥1,370 | -¥7,648 | -¥1,760 | -¥17,566 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥87,500 | ¥112,500 | -¥87,500 | ¥87,500 |
| Stock Issued | ¥1,090,805 | ¥573,382 | ¥519,604 | ¥478,051 |
| Stock Repurch. | -¥1,044 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥2,579 | ¥5,077 | ¥0 | ¥3,675 |
| Financing Cash Flow | ¥1,004,840 | ¥690,959 | ¥432,104 | ¥569,226 |
| Forex Effect | -¥1 | ¥0 | ¥0 | ¥0 |
| Net Chg. in Cash | -¥246,890 | -¥473,609 | -¥774,057 | -¥960,362 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥1,057,360 | ¥1,530,969 | ¥2,305,026 | ¥3,265,388 |
| End Cash | ¥810,470 | ¥1,057,360 | ¥1,530,969 | ¥2,305,026 |
| Free Cash Flow | -¥1,251,729 | -¥1,164,568 | -¥1,206,161 | -¥1,529,668 |